ArticleBMC surgery2025
Oncologic outcomes of multivisceral resection for locally advanced colorectal cancer: a single-center retrospective cohort study.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prediagnostic Urinary Tract-Related Manifestations and Recurrence Risk in Colorectal Cancer with Bladder Involvement.Journal of clinical medicine · 2026Article
- T4bN0 colon cancer shows worse survival than T1-2N1 disease: a multicenter real-world study in China.Translational cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThis study was aimed to evaluate the impact of multivisceral resection (MVR) on the oncologic outcomes of patients with locally advanced colorectal cancer.
methodsWe conducted a retrospective review of patients who underwent surgical resection between 2011 and 2020. Patients were divided into two groups: the MVR group and the standard resection group. Prognostic factors were compared, and the effect of MVR on oncologic outcomes was assessed.
resultsAmong 625 patients, 108 underwent MVR. The MVR group showed a significantly lower rate of lymph node metastasis (51.9% vs. 72.5%, p < 0.001), lymphovascular invasion (25.9% vs. 42.8%, p = 0.001), and perineural invasion (45.4% vs. 73.2%, p < 0.001) compared to the standard resection group. Postoperative complications were more frequent in the MVR group (57.4% vs. 26.9%, p < 0.001). Three-year disease-free survival (68.6% vs. 62.7%, p = 0.743) and overall survival (OS) (80.9% vs. 85.0%, p = 0.290) were comparable between the two groups. Multivariable analysis identified lymph node metastasis, perineural invasion, R2 resection, and absence of adjuvant chemotherapy as independent poor prognostic factors for OS.
conclusionsThe MVR group showed a significantly lower rate of lymph node metastasis and comparable oncologic outcomes. Therefore, when adjacent organ invasion is suspected, an aggressive en-bloc MVR should be considered to achieve radical resection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.